Selective Laser Trabeculoplasty in Glaucoma Treatment – Results during three Years Follow-up
Authors:
S. Sičáková; P. Výborný
Authors place of work:
Oční klinika 1. lékařské fakulty Univerzity Karlovy a Ústřední vojenské nemocnice, Praha, přednosta doc. MUDr. Jiří Pašta, CSc.
Published in the journal:
Čes. a slov. Oftal., 66, 2010, No. 5, p. 204-208
Category:
Original Article
Summary
The authors present results of their own modification of selective laser trabeculoplasty in primary open angle glaucoma and other groups of glaucoma using the laser machine Laserex Tango (wave length 532 nm, Q-switched, Nd-YAG laser, pulse duration 3 ns [nanoseconds], target diameter 400 Ūm, 80 burns, extension ? of the circumference of the anterior chamber angle, power 1.0 mJ). The intraocular pressure was measured by means of the non-contact tonometer Nidek 2000, calibrated according to the current legislation.
In the first group, the changes of the intraocular pressure (IOP) in primary open angle glaucoma in 106 eyes of 75 patients, aged 21 – 80 years, with seven controls during 36 months were followed – up. Remarkable decrease of the IOP from the baseline of 20.7 ± 4.6 mm Hg to 17.5 ± 3.1 mm Hg (one month - M1), 17.8 ± 3.5 mm Hg (3 months - M3), 17.7 ± 3.1 mm Hg (6 months - M6), 17.8 ± 2.7 mm Hg (12 months - M12), 17.9 + 2.6 mm Hg (24 months -M24), and 18.2 + 3.1 mm Hg (36 months - M36) was recorded. The average IOP decrease by 3.2 mm Hg (decrease by 15.5 %) between the baseline and the values after 1 months of treatment was proven to be statistically significant (p-value <0.0001) as well as the average difference of 2.9 mm Hg (decrease by 14.0 %), 3.0 mm Hg (decrease by 14.5 %), 2.9 mm Hg (decrease by 14.0 %), 3.0 mm Hg (decrease by 14.5 %), 2.9 mm Hg (decrease by 14.0 %), 2.8 mm Hg (decrease by 13.5 %), and 2.5 mm Hg (decrease by 12.1 %) among the baseline IOP values and the IOP values measured successively after 3, 6, 12, 24, and 36 months.
In the second group, the IOP and treatment changes were followed-up in patients with the primary open angle glaucoma with 3 controls during 36 months in 420 eyes of 263 patients (age 21 – 84 years). In the end of three years follow-up period, in 234 eyes the simplified monotherapy remained, in 146 eyes the treatment was the same as before the laser surgery, in 40 cases it was necessary to perform re-SLT, and out of this number, in 19 cases the trabeculectomy was consequently performed due to unsatisfactory IOP compensation. It was recorded remarkable IOP values decrease from the baseline 20.8 ± 4.1 mm Hg to 18.0 ± 2.8 mm Hg (12 months - M12), 17.7 ± 2.6 mm Hg (24 months - M24), and 17.7 ± 3.1 mm Hg (36 months - M36). The average IOP lowering by 2.8 mm Hg (decrease by 13.5 %) found between the baseline values and values 12 months after the SLT was found to be statistically significant (p-value < 0.0001), as well as the average difference of 3.1 mm Hg (decrease by 14.9 %) and 3.1 mm Hg (decrease by 14.9 %) among the baseline IOP values and values found consequently after 24 and 36 months.
Pigmentary glaucoma (35 eyes) – significant, but short – term effect of the SLT to the IOP decrease was observed. In two cases, shortly after the laser treatment, it was necessary due to extreme IOP elevation to perform the trabeculectomy. In 12 eyes it was necessary due to the unsatisfactory IOP compensation to repeat during one-year period the SLT procedure.
Pseudoexfoliative glaucoma (37 eyes) – very good and rapidly appearing effect of the SLT to the IOP decrease was found. In 2 eyes, during the one-year follow-up period, it was performed the phacoemulsification of the lens with artificial intraocular lens (IOL) implantation. During further follow-up, the SLT was indicated and performed again in all eyes, and after that, in other 6 eyes of this group the phacoemulsification of the lens with IOL implantation was performed.
The SLT as primary treatment (44 eyes) – all patients, even after 3 years follow-up period, are without the necessity of antiglaucomatous treatment. At the present time, the SLT was already performed in 122 eyes as the primary treatment.
SLT as termination of the treatment (80 eyes) – in the remaining group of 40 patients, there are still 35 patients without treatment after three years, the data from the others are not available.
Selective laser trabeculoplasty is effective and considerate method in the treatment of different groups of glaucoma diseases.
Key words:
selective laser trabeculoplasty, glaucoma, intraocular pressure
Zdroje
1. Alvarado, J.A., Iguchi, R., Mister, R. et al.: From the bedside to the bench and back again: predicting and improving the outcomes of SLT glaucoma therapy. Trans. Am. Ophthalmol. Soc., 107, 2009, Dec: 167–181.
2. Baser, E., Seymenoglu, R.: SLT for the treatment of intravitreal triamcinolone injection. Can. J. Ophthalmol. 44, 2009, 3: 21.
3. Cantor, L.B., Katz, L.J., Cheby, J.W. et al.: Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Curr. Med. Res. Opinion, 24, 2008, 10: 2905–2918.
4. Corcoran, K.J.: The shifting tides of glaucoma surgery. Review of Ophthalmology, E-newsletter, http:/www. revophth.com, Issue 9. 1. 2009, Vol. No 16: 09.
5. Erb, C.: Glaucoma and dry eye data from Germany – A survey of 20506 patients examines prevalence of dry eye in glaucoma patients. Ophthalmology Times Europe, 5, 2009, 8: Oct 1.
6. Funk, J.: Weiter IOD-Senkung moglich. Concept Ophthalomologie, 2, 2009, 3: 14–15.
7. Gagnon, L.: Antiglaucoma medications do not adversely or favourably affects SLT success. Annual Meeting of Canadian Ophthalmol. Society, 2009, Book of Abstracts, p. 19.
8. Kanthan, G.L., Wang, J.J., Rochtchina, E. et al.: Use of antihypertenzive medications and topical betablockers and the long-term incidence of cataract and cataract surgery. Br. J. Ophthalmol., 93, 2009, 9: 1210–1214.
9. Kumar, N., Dherani, M., Jivan, S.: Ramadan and eye drops – perspective of muslims in the UK. Br. J. Ophthalmol. 93, 2009, 4: 551–552.
10. Realini, T., Charlon, J., Hettlinger, M.: The impact of anti-inflammatory therapy on IOP reduction following SLT. Ophthal. Surgery, Lasers and Imaging, 41, 2010, 1: 100–103.
11. Rhee, D.J., Krad, O, Pasquale, L.: Ophthal. Surgery, Lasers and Imaging, 40, 2009, 5: 493–494.
12. Russo, V., Barone, A., Cosma, A. et al: Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open angle glaucoma. Eur. J. Ophthalmol., 2009, 19: 429–434.
13. Singh, D., Coote, M.A., OęHare, F.: Topical prostaglandin analogues do not affect SLT outcomes. Eye, 23, 2009, 12: 2194–2199.
14. Výborný, P., Sičáková, S.: Selektivní laserová trabekuloplastika – nové možnosti v léčbě glaukomu. Čes. a Slov. Oftal., 65, 2009, 1: 8–11.
15. Výborný, P., Sičáková, S.: 270 Selective Laser Trabeculoplasty in the Treatment of Primary Open Angle Glaucoma. 1st World Congress on Controversies in Ophthalmology, Prague, March 4–7, 2010, Program and Abstracts, p. 19.
Štítky
OphthalmologyČlánok vyšiel v časopise
Czech and Slovak Ophthalmology
2010 Číslo 5
Najčítanejšie v tomto čísle
- Indication Avastin in Ophthalmology
- Subjective Visual Perception after Laser Treatment of Myopia on two Types of Lasers
- Selective Laser Trabeculoplasty in Glaucoma Treatment – Results during three Years Follow-up
- Visual Evoked Potentials in Management of Amblyopia in Children